Positive Findings of Blood Cultures in Febrile Children Presenting with Thalassemia Major in a Tertiary Care Hospital

Objective: To assess status of bacterial pathogens in thalassemia major patients presenting with fever in a tertiary care hospital  Methods:  A retrospective descriptive study was conducted at –removed for blind review---from November, 2020 to October, 2021 in which 102 patients of thalassemia major who presented with fever and were suspicious of having septicemia were enrolled. Their demographic characteristics and pathological findings were noted in this study. Standardized approach was followed for blood withdrawal and sample collection required for performing blood cultures. The data was analyzed with SPSS version 21.  Results:  Females were in majority. Total 57 (56.0%) of patients had positive blood culture. The most frequent bacterial pathogen was Klebsiella pneumonia 13 (12.7%), followed by E-coli 11 (10.7%), staphylococcus aureus 7 (6.8%), pseudomonas 8 (7.8%) and streptococcus type pathogens 6 (5.8%).  Conclusion:  Positive culture findings were high in the thalassemia major patients who presented with fever.  

[1]  Isamme AlFayyad,et al.  Epidemiology of Thalassemia in Gulf Cooperation Council Countries: A Systematic Review , 2020, BioMed research international.

[2]  A. Taher,et al.  Thalassemia in the emergency department: special considerations for a rare disease , 2020, Annals of Hematology.

[3]  G. Bancroft,et al.  Immune responses in beta-thalassaemia: heme oxygenase 1 reduces cytokine production and bactericidal activity of human leucocytes , 2020, Scientific Reports.

[4]  G. B. Gebretekle,et al.  Practice of over-the-counter dispensary of antibiotics for childhood illnesses in Addis Ababa, Ethiopia: a simulated patient encounter study , 2019, Antimicrobial Resistance & Infection Control.

[5]  A. Piga,et al.  Challenges of blood transfusions in β-thalassemia. , 2019, Blood reviews.

[6]  A. Khalid,et al.  Reflection of treatment proficiency of hydroxyurea treated β-thalassemia serum samples through nuclear magnetic resonance based metabonomics , 2019, Scientific Reports.

[7]  A. Al-Jawabreh,et al.  Prevalence of Sero-Molecular Markers of Hepatitis C and B Viruses among Patients with β-Thalassemia Major in Northern West Bank, Palestine , 2018, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[8]  Said Y. Mohamed Thalassemia Major: Transplantation or Transfusion and Chelation. , 2017, Hematology/oncology and stem cell therapy.

[9]  I. Khan,et al.  β-Thalassemia Patients Revealed a Significant Change of Untargeted Metabolites in Comparison to Healthy Individuals , 2017, Scientific Reports.

[10]  U. Waheed,et al.  Epidemiology of Transfusion Transmitted Infection among Patients with β-Thalassaemia Major in Pakistan , 2016, Journal of blood transfusion.

[11]  A. Jetsrisuparb,et al.  Severe bacterial infections in patients with non-transfusion-dependent thalassemia: prevalence and clinical risk factors. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[12]  C. Llor,et al.  Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem , 2014, Therapeutic advances in drug safety.

[13]  R. Jain,et al.  A prospective study for prevalence and/or development of transfusion-transmitted infections in multiply transfused thalassemia major patients , 2012, Asian journal of transfusion science.

[14]  G. Rahav,et al.  Severe infections in thalassaemic patients: prevalence and predisposing factors , 2006, British journal of haematology.